Place anything here or remove it.

Place anything here you want

Today: September 16, 2024
2 weeks ago

ESC 2024: SELECT trial provides promising results for obesity-related HFpEF treatment

esc-2024:-select-trial-provides-promising-results-for-obesity-related-hfpef-treatment
ESC 2024: SELECT trial provides promising results for obesity-related HFpEF treatment

Semaglutide has the potential to be popular among diastolic heart failure HFpEF patients and clinicians alike.

Leave a Reply

Your email address will not be published.

Don't Miss